Literature DB >> 29372318

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).

David N Louis1, Pieter Wesseling2,3,4, Werner Paulus5, Caterina Giannini6, Tracy T Batchelor7, J Gregory Cairncross8, David Capper9,10, Dominique Figarella-Branger11, M Beatriz Lopes12, Wolfgang Wick13, Martin van den Bent14.   

Abstract

Mesh：

Year:  2018        PMID： 29372318     DOI： 10.1007/s00401-018-1808-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  33 in total

1.  High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.

Authors:  Kiyotaka Saito; Kiyotaka Yokogami; Kazunari Maekawa; Yuichiro Sato; Shinji Yamashita; Fumitaka Matsumoto; Asako Mizuguchi; Hideo Takeshima
Journal:  Hum Cell       Date:  2021-01-17       Impact factor: 4.174

Review 2.  Genetic and molecular epidemiology of adult diffuse glioma.

Authors:  Annette M Molinaro; Jennie W Taylor; John K Wiencke; Margaret R Wrensch
Journal:  Nat Rev Neurol       Date:  2019-06-21       Impact factor: 42.937

Review 3.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

4.  Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.

Authors:  Kiyong Na; Hyun-Soo Kim; Hyo Sup Shim; Jong Hee Chang; Seok-Gu Kang; Se Hoon Kim
Journal:  J Neurooncol       Date:  2019-02-01       Impact factor: 4.130

5.  Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas.

Authors:  Cinthya J Zepeda-Mendoza; Rachael A Vaubel; Shabnam Zarei; Cristiane M Ida; Martin Matthews; Sara Acree; Aditya Raghunathan; Caterina Giannini; Robert B Jenkins
Journal:  Acta Neuropathol       Date:  2020-03-13       Impact factor: 17.088

Review 6.  Neuro-Oncology and Radiogenomics: Time to Integrate?

Authors:  A Lasocki; M A Rosenthal; S J Roberts-Thomson; A Neal; K J Drummond
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

Review 7.  A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm.

Authors:  George S Stoyanov; Lilyana Petkova; Deyan L Dzhenkov
Journal:  Cureus       Date:  2019-12-15

8.  The Misclassification of Diffuse Gliomas: Rates and Outcomes.

Authors:  J Bryan Iorgulescu; Matthew Torre; Maya Harary; Timothy R Smith; Ayal A Aizer; David A Reardon; Jill S Barnholtz-Sloan; Arie Perry
Journal:  Clin Cancer Res       Date:  2019-01-11       Impact factor: 12.531

9.  Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?

Authors:  Kwok Ling Kam; Christina L Appin; Qinwen Mao; Sachie Ikegami; Rimas V Lukas; Marina N Nikiforova; Somak Roy; Daniel J Brat; Craig Horbinski
Journal:  J Neuropathol Exp Neurol       Date:  2020-07-01       Impact factor: 3.685

10.  Clinical implications of molecular analysis in diffuse glioma stratification.

Authors:  Masahiro Mizoguchi; Nobuhiro Hata; Daisuke Kuga; Ryusuke Hatae; Yojiro Akagi; Yuhei Sangatsuda; Yutaka Fujioka; Kosuke Takigawa; Yusuke Funakoshi; Satoshi O Suzuki; Toru Iwaki
Journal:  Brain Tumor Pathol       Date:  2021-07-15       Impact factor: 3.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.